Hospital
St.Francis Medical Center
St.Francis Medical Center was paid $12.91M by Medicaid between Jan 2018 and Jan 2021, across 289 billing codes. Its largest line is 0450, Emergency room services — 19% of everything it billed.
33Billing provider infoST.FRANCIS MEDICAL CENTER
LYNWOOD, CA 90262
LYNWOOD, CA 90262
33aNPI1487697215assigned 06/13/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$12.91M
24GClaims547,156
24DCodes billed289
24AFirst – last monthJan 2018 – Jan 2021
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#159 of 410
Median peer was paid$6.90M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 244,695 | $4.54M | |
| 2019 | 191,936 | $5.80M | |
| 2020 | 110,456 | $2.56M | |
| 2021 | 69 | $495.41 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 19% | 55,026 | 48,213 | $2.41M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6.3% | 8,244 | 6,818 | $807K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.8% | 3,966 | 3,753 | $621K |
| Z7502 | 4.7% | 15,968 | 15,763 | $604K | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.8% | 3,550 | 3,080 | $486K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.2% | 1,983 | 1,814 | $415K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.1% | 2,230 | 2,129 | $399K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.4% | 2,496 | 2,332 | $314K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.1% | 13,995 | 12,661 | $272K |
| 80053 | Comprehensive metabolic panel | 2.0% | 20,345 | 18,560 | $259K |
| 0111 | 1.9% | 632 | 572 | $250K | |
| 71046 | Radiologic examination, chest; 2 views | 1.8% | 13,336 | 12,522 | $236K |
277 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.6% | 5,265 | $209K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 29,986 | $197K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.5% | 1,108 | $194K |
| 76377 | 1.3% | 1,357 | $173K | |
| 0682 | 1.3% | 70 | $171K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 9,747 | $168K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.2% | 885 | $159K |
| Z9725 | 1.1% | 3,374 | $145K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 5,180 | $141K |
| 93976 | 1.1% | 1,240 | $141K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,615 | $117K |
| 0206 | <1% | 289 | $114K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 2,129 | $106K |
| 76801 | <1% | 1,830 | $106K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,357 | $102K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,752 | $102K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,816 | $97K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,210 | $95K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,864 | $92K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,420 | $86K |
| J3490 | Unclassified drugs | <1% | 34,992 | $83K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,271 | $83K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,749 | $83K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 433 | $82K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 411 | $79K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,216 | $74K |
| 0360 | <1% | 1,905 | $69K | |
| 93971 | <1% | 759 | $62K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 9,093 | $59K |
| 11043 | <1% | 1,516 | $59K | |
| 59025 | Fetal non-stress test | <1% | 2,421 | $56K |
| 81025 | <1% | 14,228 | $56K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,337 | $55K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,335 | $55K |
| 84484 | <1% | 7,152 | $52K | |
| 0122 | <1% | 436 | $52K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,150 | $49K |
| 84702 | <1% | 4,500 | $49K | |
| 83690 | <1% | 8,464 | $48K | |
| 76770 | <1% | 688 | $47K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,354 | $44K |
| Z7610 | <1% | 7,304 | $44K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,517 | $44K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 789 | $42K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,745 | $42K |
| 80306 | <1% | 2,490 | $42K | |
| 81001 | <1% | 12,836 | $41K | |
| 99199 | Unlisted special service, procedure or report | <1% | 1,073 | $41K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 488 | $40K |
| 83789 | <1% | 2,521 | $37K | |
| 82261 | <1% | 2,522 | $37K | |
| 83021 | <1% | 2,518 | $37K | |
| 83498 | <1% | 2,517 | $36K | |
| 83880 | <1% | 1,762 | $35K | |
| 76830 | Ultrasound, transvaginal | <1% | 550 | $34K |
| 73564 | <1% | 1,309 | $32K | |
| 90715 | <1% | 1,036 | $30K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 776 | $29K |
| 73610 | <1% | 1,364 | $29K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 540 | $29K |
| 0710 | <1% | 1,582 | $28K | |
| 0250 | <1% | 13,291 | $28K | |
| 83516 | <1% | 2,516 | $26K | |
| 73630 | <1% | 1,234 | $26K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,660 | $25K |
| 0301 | <1% | 2,230 | $24K | |
| 82776 | <1% | 2,520 | $24K | |
| 81002 | <1% | 14,487 | $24K | |
| 0762 | <1% | 465 | $23K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 427 | $23K |
| 87040 | <1% | 1,817 | $22K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,895 | $21K |
| 73130 | <1% | 924 | $20K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 748 | $20K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,257 | $20K |
| 77336 | <1% | 572 | $19K | |
| 73030 | <1% | 1,113 | $19K | |
| 86850 | <1% | 1,567 | $18K | |
| 93970 | <1% | 118 | $17K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,123 | $17K |
| 0270 | <1% | 7,567 | $16K | |
| 0300 | <1% | 2,248 | $16K | |
| 87400 | <1% | 3,282 | $16K | |
| 73502 | <1% | 588 | $15K | |
| 86900 | <1% | 3,604 | $15K | |
| 73110 | <1% | 658 | $15K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 131 | $15K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 274 | $14K |
| 86901 | <1% | 3,562 | $14K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,045 | $14K |
| 0370 | <1% | 608 | $13K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,885 | $13K |
| 87186 | <1% | 2,035 | $12K | |
| 85730 | <1% | 3,075 | $12K | |
| 93325 | <1% | 169 | $12K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,472 | $11K |
| 0761 | <1% | 917 | $11K | |
| 12001 | <1% | 288 | $11K | |
| 73590 | <1% | 491 | $11K | |
| 83605 | <1% | 1,179 | $10K | |
| 0160 | <1% | 374 | $10K | |
| 0760 | <1% | 741 | $10K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 285 | $9K |
| 73080 | <1% | 394 | $9K | |
| 0510 | <1% | 1,022 | $9K | |
| 76870 | <1% | 108 | $9K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 199 | $9K |
| 76825 | <1% | 170 | $9K | |
| 85610 | <1% | 3,220 | $9K | |
| 72100 | <1% | 318 | $8K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,072 | $8K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 284 | $8K |
| 87077 | <1% | 1,846 | $8K | |
| 70486 | <1% | 58 | $8K | |
| 86141 | <1% | 980 | $7K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,551 | $7K |
| 81000 | <1% | 3,133 | $7K | |
| 85379 | <1% | 1,025 | $7K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 243 | $6K |
| 73140 | <1% | 468 | $6K | |
| 87210 | <1% | 1,742 | $6K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,163 | $6K |
| 76827 | <1% | 170 | $6K | |
| 0121 | <1% | 13 | $5K | |
| 82805 | <1% | 194 | $5K | |
| 74018 | <1% | 336 | $5K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 286 | $5K |
| 0410 | <1% | 420 | $5K | |
| 0272 | <1% | 1,522 | $5K | |
| 87420 | <1% | 1,024 | $5K | |
| 81003 | <1% | 3,382 | $5K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,912 | $5K |
| 82803 | <1% | 273 | $5K | |
| 77290 | <1% | 40 | $5K | |
| 84145 | <1% | 332 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,119 | $5K |
| G0378 | Hospital observation service, per hour | <1% | 209 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 136 | $4K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,243 | $4K |
| 12011 | <1% | 158 | $4K | |
| 0636 | <1% | 1,156 | $4K | |
| 77417 | <1% | 203 | $4K | |
| 0306 | <1% | 1,299 | $4K | |
| 0305 | <1% | 1,708 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 867 | $4K |
| 82962 | <1% | 2,337 | $4K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 126 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,314 | $4K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,315 | $4K |
| 71020 | <1% | 186 | $4K | |
| 85018 | <1% | 1,952 | $3K | |
| 73090 | <1% | 218 | $3K | |
| 0320 | <1% | 531 | $3K | |
| 0171 | Inj, epinephrine (belcher) | <1% | 61 | $3K |
| 80185 | <1% | 152 | $3K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,006 | $3K |
| A4649 | Surgical supply; miscellaneous | <1% | 1,916 | $3K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 207 | $3K |
| 99152 | <1% | 59 | $3K | |
| 77338 | <1% | 14 | $2K | |
| 0324 | <1% | 540 | $2K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 54 | $2K |
| 73565 | <1% | 349 | $2K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 632 | $2K |
| 83735 | <1% | 443 | $2K | |
| 76641 | <1% | 55 | $2K | |
| 84703 | <1% | 338 | $2K | |
| 93017 | <1% | 56 | $2K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 429 | $2K |
| 0258 | <1% | 1,186 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 105 | $2K |
| 0730 | <1% | 533 | $2K | |
| 29125 | <1% | 52 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 624 | $2K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 18 | $2K |
| 36600 | <1% | 184 | $2K | |
| 0402 | <1% | 470 | $2K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 12 | $2K |
| 0412 | <1% | 40 | $2K | |
| 85027 | <1% | 313 | $1K | |
| 84439 | <1% | 270 | $1K | |
| 87190 | <1% | 657 | $1K | |
| 87147 | <1% | 468 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 206 | $1K |
| 96376 | <1% | 299 | $1K | |
| 80076 | <1% | 203 | $1K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 265 | $1K |
| G0379 | Direct admission of patient for hospital observation care | <1% | 28 | $1K |
| 73060 | <1% | 27 | $1K | |
| 73552 | <1% | 51 | $1K | |
| 82140 | <1% | 82 | $1K | |
| 77300 | <1% | 32 | $1K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 64 | $1K |
| 74022 | <1% | 44 | $1K | |
| 87070 | <1% | 217 | $990.89 | |
| 87081 | <1% | 249 | $987.56 | |
| 82731 | <1% | 36 | $969.27 | |
| 87205 | <1% | 269 | $890.14 | |
| 10060 | <1% | 74 | $889.33 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 65 | $869.84 |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 56 | $824.59 |
| A0425 | Ground mileage, per statute mile | <1% | 237 | $803.79 |
| 88304 | <1% | 301 | $734.85 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 379 | $710.91 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 14 | $706.93 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 153 | $676.68 |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 73 | $639.19 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 126 | $598.99 |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 92 | $533.70 |
| 72170 | <1% | 13 | $510.30 | |
| 82728 | <1% | 63 | $504.12 | |
| 0471 | <1% | 263 | $456.45 | |
| 94726 | <1% | 17 | $439.06 | |
| 80061 | Lipid panel | <1% | 13 | $408.97 |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 12 | $379.54 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 251 | $367.95 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 168 | $366.44 |
| L8699 | Prosthetic implant, not otherwise specified | <1% | 25 | $352.80 |
| 82550 | <1% | 74 | $337.01 | |
| 72050 | <1% | 13 | $332.67 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 14 | $329.80 |
| 0307 | <1% | 786 | $324.88 | |
| 99201 | <1% | 26 | $309.01 | |
| 94375 | <1% | 19 | $307.06 | |
| 85384 | <1% | 74 | $285.26 | |
| 83615 | <1% | 67 | $285.01 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 243 | $253.68 |
| 0302 | <1% | 759 | $237.17 | |
| 29515 | <1% | 26 | $232.42 | |
| J1815 | Injection, insulin, per 5 units | <1% | 16 | $228.11 |
| 82247 | <1% | 69 | $205.80 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 25 | $205.52 |
| 82248 | <1% | 70 | $202.50 | |
| K0001 | Standard wheelchair | <1% | 49 | $181.83 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 27 | $179.76 |
| 84100 | <1% | 62 | $169.43 | |
| 87390 | <1% | 12 | $138.60 | |
| 84550 | <1% | 71 | $137.80 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 142 | $136.30 |
| 12002 | <1% | 12 | $135.00 | |
| 85362 | <1% | 44 | $131.40 | |
| 29105 | <1% | 12 | $110.60 | |
| 94760 | <1% | 63 | $99.44 | |
| 20610 | <1% | 19 | $73.79 | |
| 99070 | <1% | 70 | $71.79 | |
| 0637 | <1% | 31 | $70.80 | |
| 73100 | <1% | 15 | $69.05 | |
| 85007 | <1% | 32 | $68.70 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 14 | $68.32 |
| 82150 | <1% | 14 | $61.85 | |
| 84112 | <1% | 93 | $58.01 | |
| 86140 | <1% | 16 | $54.63 | |
| 84460 | <1% | 13 | $44.82 | |
| 84450 | <1% | 13 | $43.63 | |
| 86592 | <1% | 13 | $41.39 | |
| A4615 | Cannula, nasal | <1% | 30 | $22.34 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 13 | $16.90 |
| 0771 | <1% | 362 | $13.03 | |
| 0271 | <1% | 70 | $0.70 | |
| 0922 | 0% | 153 | $0.00 | |
| 0350 | 0% | 38 | $0.00 | |
| 0720 | 0% | 215 | $0.00 | |
| 0420 | 0% | 154 | $0.00 | |
| 0170 | 0% | 24 | $0.00 | |
| 0352 | 0% | 16 | $0.00 | |
| E0431 | Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing | 0% | 48 | $0.00 |
| Q4051 | Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) | 0% | 40 | $0.00 |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 0% | 233 | $0.00 |
| 0721 | 0% | 138 | $0.00 | |
| 0312 | 0% | 245 | $0.00 | |
| E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | 0% | 104 | $0.00 |
| 0430 | 0% | 14 | $0.00 | |
| 0483 | 0% | 15 | $0.00 | |
| 0489 | 0% | 16 | $0.00 | |
| 0351 | 0% | 14 | $0.00 | |
| 76818 | 0% | 40 | $0.00 | |
| 0750 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBASTOS, CARMEN (PATIENT FINANCIAL SERVICES DIRECTOR)